Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.170
+0.040 (3.54%)
At close: Sep 11, 2026, 4:00 PM EDT
1.180
+0.010 (0.85%)
After-hours: Sep 11, 2026, 7:30 PM EDT
Pliant Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Pliant Therapeutics stock have an average target of $2.00, which predicts a 70.94% increase from the current stock price of 1.17.
Price Target: $2.00 (+70.94%)
Analyst Consensus: Hold
Price Target
Chart* Price targets were last updated on Aug 13, 2026.
Analyst Ratings
The average analyst rating for Pliant Therapeutics stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '25 | Feb '26 | Mar '26 | May '26 | Jun '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Hold | 6 | 5 | 4 | 4 | 4 | 4 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 7 | 6 | 6 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Sell Maintains n/a | Sell | Maintains | n/a | n/a | Aug 18, 2026 |
| Canaccord Genuity | Canaccord Genuity | Hold Reiterates $3 | Hold | Reiterates | $3 | +156.41% | Aug 13, 2026 |
Unknown Analyst Oppenheimer No rating | Oppenheimer | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Aug 13, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $2 | Hold | Maintains | $2 | +70.94% | Aug 12, 2026 |
| Needham | Needham | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Aug 12, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.43
from -2.40
EPS Next Year
-1.28
from -1.43
EPS and Forward PE are based on non-GAAP adjusted numbers.